drugset / Trial / NCT01456260
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to evaluate the safety of TAK-438, once daily (QD), during long-term concomitant non-steroidal anti-inflammatory drug (NSAID) therapy in patients with a history of gastric or duodenal ulcer who require long-term therapy of NSAID.
Timeline
- Start
- 2011-09
- Primary completion
- —
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lansoprazole | Other / unclassified | 15 mg | Oral |
| Subject | Vonoprazan | Other / unclassified | 10 mg | Oral |
| Subject | Vonoprazan | Other / unclassified | 20 mg | Oral |